Insider Trading & Ownership - LYNCH DANIEL

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for LYNCH DANIEL

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-05-16
Option Award
2024-05-17
4:07 pm
N/A
2034-05-16
SpringWorks Therapeutics Inc.SWTXLYNCH DANIEL
Director
16,311$0318,160
(Direct)
View
2023-06-13
Option Award
2023-06-15
5:02 pm
N/A
2033-06-13
2seventy bio Inc.TSVTLYNCH DANIEL
Director
25,300$037,953
(Direct)
View
2023-05-24
Option Award
2023-05-25
4:28 pm
N/A
2033-05-24
SpringWorks Therapeutics Inc.SWTXLYNCH DANIEL
Director
18,422$0315,623
(Direct)
View
2022-06-08
Option Award
2022-06-09
6:20 pm
N/A
2032-06-08
2seventy bio Inc.TSVTLYNCH DANIEL
Director
21,600$027,053
(Direct)
View
2022-05-19
Option Award
2022-05-20
5:43 pm
N/A
2032-05-19
SpringWorks Therapeutics Inc.SWTXLYNCH DANIEL
Director
20,136$0312,519
(Direct)
View
2021-11-11
Other
2021-11-17
08:57 am
N/A
2023-01-16
bluebird bio Inc.BLUELYNCH DANIEL
Director
77,942$077,801
(Direct)
View
2021-11-11
Option Award
2021-11-16
06:44 am
N/A
2023-01-16
2seventy bio Inc.TSVTLYNCH DANIEL
Director
30,586$033,236
(Direct)
View

Ownership
2021-10-21
8:39 pm
N/A
2030-07-22
Xilio Therapeutics Inc.XLOLYNCH DANIEL
Director
10% Owner
0$0335,394
(Direct)
View
2021-06-15
Option Award
2021-06-17
4:08 pm
N/A
2031-06-15
bluebird bio Inc.BLUELYNCH DANIEL
Director
11,353$019,312
(Direct)
View
2021-05-20
Option Award
2021-05-21
4:31 pm
N/A
2031-05-20
SpringWorks Therapeutics Inc.SWTXLYNCH DANIEL
Director
8,104$0299,381
(Direct)
View
2020-12-17
Ownership
2021-02-16
4:12 pm
N/A
N/A
Translate Bio Inc.TBIOLYNCH DANIEL
Director
100,000$0221,825
(Direct)
View
2020-12-08
Ownership
2021-02-11
4:30 pm
N/A
N/A
SpringWorks Therapeutics Inc.SWTXLYNCH DANIEL
Director
100,000$0459,577
(Direct)
View

Ownership
2021-01-06
9:42 pm
N/A
N/A
Omega Alpha SPACOMEGLYNCH DANIEL
Director
0$035,000
(Direct)
View
2020-06-24
Option Award
2020-06-26
4:08 pm
N/A
2030-06-24
Blueprint Medicines CorpBPMCLYNCH DANIEL
Director
6,750$0132,404
(Direct)
View
2020-06-19
Exercise
2020-06-23
4:18 pm
N/A
N/A
Blueprint Medicines CorpBPMCLYNCH DANIEL
Director
1,312$0125,654
(Direct)
View
2020-06-18
Option Award
2020-06-22
4:27 pm
N/A
2030-06-18
bluebird bio Inc.BLUELYNCH DANIEL
Director
6,559$012,159
(Direct)
View
2020-06-16
Option Award
2020-06-17
5:52 pm
N/A
2030-06-15
Translate Bio Inc.TBIOLYNCH DANIEL
Director
18,900$018,900
(Direct)
View
2020-06-10
Option Award
2020-06-12
08:00 am
N/A
2030-06-10
Surface Oncology Inc.SURFLYNCH DANIEL
Director
12,000$012,000
(Direct)
View
2020-05-20
Option Award
2020-05-22
4:37 pm
N/A
2030-05-20
SpringWorks Therapeutics Inc.SWTXLYNCH DANIEL
Director
10% Owner
7,464$07,464
(Direct)
View
2020-04-03
Gift
2020-04-07
4:34 pm
N/A
N/A
Blueprint Medicines CorpBPMCLYNCH DANIEL
Director
50,000$0124,342
(Direct)
View